<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37217471</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program.</ArticleTitle><Pagination><StartPage>2914</StartPage><MedlinePgn>2914</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2914</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-38388-7</ELocationID><Abstract><AbstractText>Long COVID, or complications arising from COVID-19 weeks after infection, has become a central concern for public health experts. The United States National Institutes of Health founded the RECOVER initiative to better understand long COVID. We used electronic health records available through the National COVID Cohort Collaborative to characterize the association between SARS-CoV-2 vaccination and long COVID diagnosis. Among patients with a COVID-19 infection between August 1, 2021 and January 31, 2022, we defined two cohorts using distinct definitions of long COVID-a clinical diagnosis (n&#x2009;=&#x2009;47,404) or a previously described computational phenotype (n&#x2009;=&#x2009;198,514)-to compare unvaccinated individuals to those with a complete vaccine series prior to infection. Evidence of long COVID was monitored through June or July of 2022, depending on patients' data availability. We found that vaccination was consistently associated with lower odds and rates of long COVID clinical diagnosis and high-confidence computationally derived diagnosis after adjusting for sex, demographics, and medical history.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Brannock</LastName><ForeName>M Daniel</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0001-8095-547X</Identifier><AffiliationInfo><Affiliation>RTI International, Durham, NC, USA. mbrannock@rti.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chew</LastName><ForeName>Robert F</ForeName><Initials>RF</Initials><Identifier Source="ORCID">0000-0002-6979-1766</Identifier><AffiliationInfo><Affiliation>RTI International, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Preiss</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-7966-527X</Identifier><AffiliationInfo><Affiliation>RTI International, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hadley</LastName><ForeName>Emily C</ForeName><Initials>EC</Initials><Identifier Source="ORCID">0000-0003-0074-4344</Identifier><AffiliationInfo><Affiliation>RTI International, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redfield</LastName><ForeName>Signe</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5428-6054</Identifier><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, Pomfret, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMurry</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leese</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girvin</LastName><ForeName>Andrew T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crosskey</LastName><ForeName>Miles</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CoVar Applied Technologies, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Andrea G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>iTHRIV, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-2723-5902</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Biomedical Informatics and Hematology and Medical Ontology, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funk</LastName><ForeName>Michele Jonsson</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Emily R</ForeName><Initials>ER</Initials><Identifier Source="ORCID">0000-0002-6840-9756</Identifier><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9114-8737</Identifier><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0001-5437-2545</Identifier><AffiliationInfo><Affiliation>Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>N3C</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>RECOVER Consortia</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 TR004406</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104940</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2022 Oct 07:2022.10.06.22280795. doi: 10.1101/2022.10.06.22280795</RefSource><PMID Version="1">36238713</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>St&#xfc;rmer</LastName><ForeName>Til</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Loomba</LastName><ForeName>Johanna J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koraishy</LastName><ForeName>Farrukh M</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Divers</LastName><ForeName>Jasmin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thorpe</LastName><ForeName>Lorna E</ForeName><Initials>LE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horwitz</LastName><ForeName>Leora</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Katz</LastName><ForeName>Stuart</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>23</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37217471</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-38388-7</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-38388-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CDC. CDC Museum COVID-19 timeline. https://www.cdc.gov/museum/timeline/covid19.html (2022).</Citation></Reference><Reference><Citation>WHO. Coronavirus (COVID-19) dashboard. https://covid19.who.int/ (2022)</Citation></Reference><Reference><Citation>Lerner AM, et al. Toward understanding COVID-19 recovery: National Institutes of Health Workshop on postacute COVID-19. Ann. Intern. Med. 2021;174:999&#x2013;1003. doi: 10.7326/M21-1043.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-1043</ArticleId><ArticleId IdType="pmc">PMC8025940</ArticleId><ArticleId IdType="pubmed">33780290</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325:2015&#x2013;2016. doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, et al. Case definition working group on post-COVID-19 condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., McCorkell L., Vogel J. M. &amp; Topol E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133&#x2013;146 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, et al. Characterizing long COVID: deep phenotype of a complex condition. EBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, et al. Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit. Health. 2022;4:e532&#x2013;e541. doi: 10.1016/S2589-7500(22)00048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning identifies long COVID patterns from electronic health records. Nat. Med. 29, 47&#x2013;48 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9838487</ArticleId><ArticleId IdType="pubmed">36639563</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVER: researching COVID to enhance recovery. https://recovercovid.org/ (2022).</Citation></Reference><Reference><Citation>Haendel MA, et al. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J. Am. Med. Inform. Assoc. 2021;28:427&#x2013;443. doi: 10.1093/jamia/ocaa196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack FP, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, et al. Effectiveness of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccines for preventing coronavirus disease 2019 hospitalizations in the United States. Clin. Infect. Dis. 2022;74:1515&#x2013;1524. doi: 10.1093/cid/ciab687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab687</ArticleId><ArticleId IdType="pmc">PMC8436392</ArticleId><ArticleId IdType="pubmed">34358310</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis SN, Durieux JC, Mouchati C, Perez JA, McComsey GA. The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: a multicenter study from a large National Health Research Network. Open Forum Infect. Dis. 2022;9:ofac228. doi: 10.1093/ofid/ofac228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon, M. A., Luginbuhl, R. D. &amp; Parker, R. Reduced incidence of long-COVID symptoms related to administration of COVID-19 vaccines both before COVID-19 diagnosis and up to 12 weeks after. Preprint at bioRxiv10.1101/2021.11.17.21263608 (2021).</Citation></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum. Infect. Dis. 2022;9:ofac464. doi: 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, et al. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS ONE. 2022;17:e0278825. doi: 10.1371/journal.pone.0278825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): a prospective cohort study. Vaccine. 2022;40:4424&#x2013;4431. doi: 10.1016/j.vaccine.2022.05.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.05.090</ArticleId><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M. et al. Effect of SARS-CoV-2 vaccination on symptoms from post-acute sequelae of COVID-19: results from the nationwide VAXILONG study. Vaccines10, 46 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnivesky JP, et al. Association of vaccination with the persistence of post-COVID symptoms. J. Gen. Intern. Med. 2022;37:1748&#x2013;1753. doi: 10.1007/s11606-022-07465-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07465-w</ArticleId><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein BA, Bhavsar NA, Phelan M, Pencina MJ. Controlling for informed presence bias due to the number of health encounters in an electronic health record. Am. J. Epidemiol. 2016;184:847&#x2013;855. doi: 10.1093/aje/kww112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kww112</ArticleId><ArticleId IdType="pmc">PMC5152663</ArticleId><ArticleId IdType="pubmed">27852603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauring AS, et al. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. BMJ. 2022;376:e069761. doi: 10.1136/bmj-2021-069761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069761</ArticleId><ArticleId IdType="pmc">PMC8905308</ArticleId><ArticleId IdType="pubmed">35264324</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews N, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N. Engl. J. Med. 2022;386:1532&#x2013;1546. doi: 10.1056/NEJMoa2119451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2119451</ArticleId><ArticleId IdType="pmc">PMC8908811</ArticleId><ArticleId IdType="pubmed">35249272</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. COVID data tracker. https://covid.cdc.gov/covid-data-tracker/#variant-proportions (2022).</Citation></Reference><Reference><Citation>Menni C, et al. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. Lancet Infect. Dis. 2022;22:1002&#x2013;1010. doi: 10.1016/S1473-3099(22)00146-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00146-3</ArticleId><ArticleId IdType="pmc">PMC8993156</ArticleId><ArticleId IdType="pubmed">35405090</ArticleId></ArticleIdList></Reference><Reference><Citation>Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20:488&#x2013;495. doi: 10.1097/EDE.0b013e3181a819a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181a819a1</ArticleId><ArticleId IdType="pmc">PMC2744485</ArticleId><ArticleId IdType="pubmed">19525685</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos HMM, et al. Does prevention of risk behaviour in primary care require a gender-specific approach? A cross-sectional study. Fam. Pract. 2013;30:179&#x2013;184. doi: 10.1093/fampra/cms064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cms064</ArticleId><ArticleId IdType="pubmed">23027999</ArticleId></ArticleIdList></Reference><Reference><Citation>Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J. Adv. Nurs. 2005;49:616&#x2013;623. doi: 10.1111/j.1365-2648.2004.03331.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2004.03331.x</ArticleId><ArticleId IdType="pubmed">15737222</ArticleId></ArticleIdList></Reference><Reference><Citation>Keene J, Li X. Age and gender differences in health service utilization. J. Public Health. 2005;27:74&#x2013;79. doi: 10.1093/pubmed/fdh208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdh208</ArticleId><ArticleId IdType="pubmed">15637107</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, et al. Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborative. J. Am. Med. Inform. Assoc. 2022;29:609&#x2013;618. doi: 10.1093/jamia/ocab217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab217</ArticleId><ArticleId IdType="pmc">PMC8500110</ArticleId><ArticleId IdType="pubmed">34590684</ArticleId></ArticleIdList></Reference><Reference><Citation>Young JC, Conover MM, Funk MJ. Measurement error and misclassification in electronic medical records: methods to mitigate bias. Curr. Epidemiol. Rep. 2018;5:343&#x2013;356. doi: 10.1007/s40471-018-0164-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40471-018-0164-x</ArticleId><ArticleId IdType="pmc">PMC9141310</ArticleId><ArticleId IdType="pubmed">35633879</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. COVID-19 vaccination data in the United States. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/distributing/about-vaccine-data.html (2022).</Citation></Reference><Reference><Citation>Stang PE, et al. Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership. Ann. Intern. Med. 2010;153:600&#x2013;606. doi: 10.7326/0003-4819-153-9-201011020-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak, G. et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inform. 216, 574&#x2013;578 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. https://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary:gender (2023).</Citation></Reference><Reference><Citation>CDC. Long COVID or post-COVID conditions. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html (2022).</Citation></Reference><Reference><Citation>Kirby JC, et al. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am. Med. Inform. Assoc. 2016;23:1046&#x2013;1052. doi: 10.1093/jamia/ocv202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv202</ArticleId><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole SR, Hern&#xe1;n MA. Constructing inverse probability weights for marginal structural models. Am. J. Epidemiol. 2008;168:656&#x2013;664. doi: 10.1093/aje/kwn164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwn164</ArticleId><ArticleId IdType="pmc">PMC2732954</ArticleId><ArticleId IdType="pubmed">18682488</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins JM, Hern&#xe1;n MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550&#x2013;560. doi: 10.1097/00001648-200009000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-200009000-00011</ArticleId><ArticleId IdType="pubmed">10955408</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat. Med. 2016;35:5642&#x2013;5655. doi: 10.1002/sim.7084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7084</ArticleId><ArticleId IdType="pmc">PMC5157758</ArticleId><ArticleId IdType="pubmed">27549016</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Meer T, Te Grotenhuis M, Pelzer B. Influential cases in multilevel modeling: a methodological comment. Am. Sociol. Rev. 2010;75:173&#x2013;178. doi: 10.1177/0003122409359166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003122409359166</ArticleId></ArticleIdList></Reference><Reference><Citation>CoxPHFitter &#x2014; lifelines 0.27.1 documentation. https://lifelines.readthedocs.io/en/latest/fitters/regression/CoxPHFitter.html (2022).</Citation></Reference><Reference><Citation>Park S, Hendry DJ. Reassessing Schoenfeld residual tests of proportional hazards in political science event history analyses. Am. J. Pol. Sci. 2015;59:1072&#x2013;1087. doi: 10.1111/ajps.12176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajps.12176</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453&#x2013;1457. doi: 10.1016/S0140-6736(07)61602-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Palantir Foundry. Palantir. https://www.palantir.com/platforms/foundry/ (2023).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>